NMD PHARMA APS has a total of 12 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, Republic of Korea and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are GRINDEKS JOINT STOCK COMPANY, SSV THERAPEUTICS INC and INST RECH CHIM BIOLOG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Republic of Korea | 2 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Hong Kong | 1 | |
#8 | Mexico | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Labelle Marc | 8 |
#2 | Holm Pedersen Thomas | 7 |
#3 | Elsborg Olesen Claus | 7 |
#4 | Broch-Lips Martin | 5 |
#5 | Knutsen Lars J S | 3 |
#6 | Bækgaard Nielsen Ole | 3 |
#7 | Marc Labelle | 2 |
#8 | Olesen Claus Elsborg | 2 |
#9 | Pedersen Thomas Holm | 2 |
#10 | Broch Lips Martin | 2 |
Publication | Filing date | Title |
---|---|---|
US2019185409A1 | Compounds For The Treatment Of Neuromuscular Disorders | |
US2019185437A1 | Compounds for the treatment of neuromuscular disorders | |
US2019183833A1 | Compounds For The Treatment Of Neuromuscular Disorders |